SCHEMBL7659998

SCHEMBL7659998

CCCCC(NC(=O)c1ccc(NC(=O)c2ccc3ccccc3c2)cc1C)C(=O)CNC(C)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CASP1 P29466 2/20 0.45
CCKBR P32239 1/20 0.44
NPC1 O15118 6/20 0.43
RAB9A P51151 6/20 0.43
PYGL P06737 1/20 0.43
CYP2C9 P11712 1/20 0.43
CNR2 P34972 1/20 0.42
CASP3 P42574 2/20 0.41
SENP7 Q9BQF6 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
DEGS1 O15121 1/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7668106 0.92 CASP1 (0.46) MEN1KMT2ACASP1CCKBRNPC1
SCHEMBL7668656 0.90 KMT2A (0.52) MEN1KMT2ACASP1CCKBRNPC1
SCHEMBL7659961 0.82 MEN1 (0.52) MEN1KMT2ACASP1CCKBRNPC1
SCHEMBL7392219 0.79 PAX8 (0.47) MEN1KMT2ANPC1RAB9AL3MBTL1
SCHEMBL7683061 0.78 PYGL (0.43) CASP1CCKBRNPC1RAB9APYGL
SCHEMBL7654043 0.77 ALDH1A1 (0.54) KMT2ACCKBRHDAC3HDAC1HDAC2
SCHEMBL7421589 0.76 PYGL (0.43) CASP1CCKBRPYGLCYP2C9ALDH1A1
SCHEMBL7385051 0.75 PTPN1 (0.46) CCKBRNPC1RAB9AHDAC3HDAC1
SCHEMBL7696690 0.75 CAPN1 (0.54) CASP1CCKBRPYGLCYP2C9CNR2
SCHEMBL7666410 0.74 CCKBR (0.42) MEN1KMT2ACASP1CCKBRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed